Back
Sep 27
Education
PRO 04 - Liquid Biopsies in Cancer
MODERATOR(S)
Aadel Chaudhuri, MD, PhD - Mayo Clinic
Abhijit Patel, MD, PhD - Yale University
session DESCRIPTION
Liquid biopsy technologies, particularly circulating tumor DNA (ctDNA), are an emerging tool in precision oncology with growing relevance in radiation oncology. This session will focus on the current and near-term clinical applications of ctDNA, including noninvasive tumor genotyping, early cancer detection, and minimal residual disease (MRD) monitoring. Expert physician-scientists will present recent data that highlight the strengths, limitations, and practical considerations for using liquid biopsy in clinical workflows.
learning objectives
- • Understand the basics regarding circulating tumor DNA (ctDNA) and liquid biopsy technologies and applications.
- • Understand the utility of ctDNA for noninvasive genotyping, early cancer detection, and minimal residual disease detection and monitoring.
Credits
| AMA PRA Category 1 Credits: | 1.00 |
Presentations
-
01:47pm - 02:00pm PT
Questions and Answers
Speaker: Abhijit Patel, MD, PhD - Yale University, New Haven -
01:00pm - 01:02pm PT
Introduction
Speaker: Aadel Chaudhuri, MD, PhD - Mayo Clinic, Rochester -
01:00pm - 02:00pm PT
Liquid Biopsies in Cancer
Speaker: Abhijit Patel, MD, PhD - Yale University, New Haven -
01:00pm - 02:00pm PT
Liquid Biopsies in Cancer
Speaker: Aadel Chaudhuri, MD, PhD - Mayo Clinic, Rochester -
01:02pm - 01:17pm PT
ctDNA for Blood-based Noninvasive Genotyping
Speaker: Scott Bratman, MD, PhD - University of Toronto, Toronto -
01:17pm - 01:32pm PT
Liquid Biopsy Early Detection of Cancer
Speaker: Aadel Chaudhuri, MD, PhD - Mayo Clinic, Rochester -
01:20pm - 01:30pm PT
-
01:32pm - 01:47pm PT
Liquid Biopsies for Detection of Minimal Residual Disease
Speaker: Maximilian Diehn, MD, PhD - Stanford University, Stanford